Cargando…

Recent evidence in the etiology and treatment for diabetic kidney disease

Etiology and therapeutic targets of diabetic nephropathy. [Image: see text]

Detalles Bibliográficos
Autor principal:	Shikata, Kenichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Jdi Updates
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089001/ https://www.ncbi.nlm.nih.gov/pubmed/33031619 http://dx.doi.org/10.1111/jdi.13433

Ejemplares similares

Diabetic kidney disease: Its current trends and future therapeutic perspectives
por: Koya, Daisuke
Publicado: (2019)

Recent updates and future perspectives on gestational diabetes mellitus: An important public health challenge
por: Chu, Leo Check Hei, et al.
Publicado: (2021)

Dietary recommendations for type 2 diabetes patients: Lessons from recent clinical and basic research in Asia
por: Seino, Yusuke, et al.
Publicado: (2019)

Cardiovascular disease in patients with type 2 diabetes
por: Jeon, Ja Young, et al.
Publicado: (2022)

Update in the epidemiology, risk factors, screening, and treatment of diabetic retinopathy
por: Lin, Kuan‐Yu, et al.
Publicado: (2021)

New prospects for incretin‐related drugs in the treatment of type 2 diabetes
por: Kimura, Tomohiko, et al.
Publicado: (2020)

Updates in diabetic neuropathy: A call for new diagnostic and treatment approaches
por: Aso, Yoshimasa
Publicado: (2021)

New perspective on type 2 diabetes, dyslipidemia and non‐alcoholic fatty liver disease
por: Matsuzaka, Takashi, et al.
Publicado: (2020)

In search of the optimal management strategy for non‐alcoholic fatty liver disease in type 2 diabetes patients
por: Lee, Chi‐Ho, et al.
Publicado: (2020)

Clinical evidence regarding factors linking metabolic abnormal obesity to pancreatic β‐cell dysfunction
por: Watada, Hirotaka
Publicado: (2020)

Advancements in transplantation therapy for diabetes: Pancreas, islet and stem cell
por: Nakamura, Toshihiro, et al.
Publicado: (2020)

A new perspective on the biguanide, metformin therapy in type 2 diabetes and lactic acidosis
por: Hotta, Nigishi
Publicado: (2019)

Diabetic polyneuropathy: Progress in diagnostic strategy and novel target discovery, but stagnation in drug development
por: Himeno, Tatsuhito, et al.
Publicado: (2019)

One year into the clash of pandemics of diabetes and COVID‐19: Lessons learnt and future perspectives
por: Lui, David Tak Wai, et al.
Publicado: (2021)

Two types of fulminant type 1 diabetes mellitus: Immune checkpoint inhibitor‐related and conventional
por: Imagawa, Akihisa
Publicado: (2020)

SGLT2 inhibitors for genetic and acquired insulin resistance: Considerations for clinical use
por: Hosokawa, Yusei, et al.
Publicado: (2020)

New perspectives on insulin therapy
por: Araki, Eiichi, et al.
Publicado: (2020)

Beginning of a new era in glucagon research: Breakthrough by the new glucagon assay
por: Kawamori, Dan
Publicado: (2020)

Obesity, metabolic syndrome and bariatric surgery: A narrative review
por: Jia, Weiping
Publicado: (2020)

The journey to understanding incretin systems: Theory, practice and more theory
por: Yabe, Daisuke, et al.
Publicado: (2019)

Update on the efficacy and safety of sodium–glucose cotransporter 2 inhibitors in Asians and non‐Asians
por: Fujita, Yoshihito, et al.
Publicado: (2019)

Blood glucose control: Where are we?
por: Lee, Moon‐Kyu
Publicado: (2021)

Impaired insulin secretion and related factors in East Asian individuals
por: Nakamura, Akinobu, et al.
Publicado: (2021)

A new era of diabetic kidney disease treatment with sodium–glucose cotransporter‐2 inhibitors
por: Kume, Shinji, et al.
Publicado: (2022)

Recent updates in factors associated with incidence and screening of diabetic eye disease
por: Sone, Hirohito
Publicado: (2023)

Current status of diabetic kidney disease and latest trends in management
por: Kim, Min Kyung, et al.
Publicado: (2022)

Effectiveness of the Shenzhuo formula in the treatment of patients with macroalbuminuria secondary to diabetic kidney disease: protocol update and statistical analysis plan
por: Wei, Yu, et al.
Publicado: (2022)

Recent developments on dry eye disease treatment compounds
por: Colligris, Basilio, et al.
Publicado: (2014)

Updates of incretin‐related drugs for the treatment of type 2 diabetes
por: Araki, Hirotaka, et al.
Publicado: (2022)

Effects of nutrient metabolism on pancreatic β‐cell mass and function: Recent findings
por: Yasuda, Takuma, et al.
Publicado: (2023)

Keloid treatments: an evidence-based systematic review of recent advances
por: Walsh, Laura A., et al.
Publicado: (2023)

Statistical analysis plan for Better Evidence for Selecting Transplant Fluids (BEST-Fluids): a randomised controlled trial of the effect of intravenous fluid therapy with balanced crystalloid versus saline on the incidence of delayed graft function in deceased donor kidney transplantation
por: Pascoe, Elaine M., et al.
Publicado: (2022)

Evidence and implications of abnormal predictive coding in dementia
por: Kocagoncu, Ece, et al.
Publicado: (2021)

Sarcopenia in elderly diabetes
por: Wen, Chen‐Yu, et al.
Publicado: (2022)

NAVKIDS(2) trial: a multi-centre, waitlisted randomised controlled trial of a patient navigator intervention in children with chronic kidney disease — statistical analysis plan and update to the protocol
por: van Zwieten, Anita, et al.
Publicado: (2022)

Updates on dyslipidemia in patients with diabetes
por: Ide, Shintaro, et al.
Publicado: (2023)

Update to the FOCUS, AFFINITY and EFFECTS trials studying the effect(s) of fluoxetine in patients with a recent stroke: statistical analysis plan for the trials and for the individual patient data meta-analysis
por: Mead, Gillian Elizabeth, et al.
Publicado: (2020)

The FOCUS, AFFINITY and EFFECTS trials studying the effect(s) of fluoxetine in patients with a recent stroke: statistical and health economic analysis plan for the trials and for the individual patient data meta-analysis
por: Graham, Catriona, et al.
Publicado: (2017)

Update information on type 1 diabetes in children/adolescents and adults
por: Miura, Junnosuke, et al.
Publicado: (2023)

Mothers After Gestational Diabetes in Australia Diabetes Prevention Program (MAGDA-DPP) post-natal intervention: an update to the study protocol for a randomized controlled trial
por: Shih, Sophy TF, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_4j2dh1al0tbloif8aeg789gpvl